SCHEMBL6067757

SCHEMBL6067757

Oc1cc(O)c(-c2cccs2)c(O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPS6KB2 Q9UBS0 1/20 0.48
QPCT Q16769 1/20 0.47
ERN1 O75460 1/20 0.43
KCNH2 Q12809 1/20 0.42
BCL2 P10415 1/20 0.41
MCL1 Q07820 1/20 0.41
PARP1 P09874 1/20 0.40
PARP2 Q9UGN5 1/20 0.40
LTA4H P09960 1/20 0.39
NQO1 P15559 1/20 0.39
TMIGD3 P0DMS9 2/20 0.39
ADORA2A P29274 2/20 0.39
ADORA1 P30542 2/20 0.39
MEN1 O00255 2/20 0.39
MAPT P10636 2/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6067994 0.87 QPCT (0.42) RPS6KB2QPCTERN1BCL2MCL1
SCHEMBL6068070 0.87 QPCT (0.42) RPS6KB2QPCTERN1PARP1PARP2
SCHEMBL6067926 0.85 RPS6KB2 (0.47) RPS6KB2ERN1KCNH2LTA4HTMIGD3
SCHEMBL6068012 0.83 MEN1 (0.48) RPS6KB2ERN1KCNH2MEN1MAPT
SCHEMBL6068077 0.83 ALDH1A1 (0.47) RPS6KB2ERN1MEN1MAPTKMT2A
SCHEMBL6068011 0.82 RPS6KB2 (0.46) RPS6KB2QPCTERN1MEN1MAPT
SCHEMBL6067827 0.82 RPS6KB2 (0.47) RPS6KB2ERN1KCNH2LTA4HTMIGD3
SCHEMBL6068015 0.78 TMIGD3 (0.45) RPS6KB2QPCTERN1BCL2MCL1
SCHEMBL6067982 0.77 MAPT (0.47) RPS6KB2QPCTERN1TMIGD3ADORA2A
SCHEMBL6068213 0.76 ERN1 (0.49) RPS6KB2QPCTERN1KCNH2LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100349886-C 1, 3-dihydroxybenzene derivatives and coloring agents containing the same WELLA AG (US) 2007-11-21 CN disclosed
US-7125428-B2 1,3-Dihydroxybenzene derivatives and colorants containing said compounds WELLA AG (DE) 2006-10-24 US disclosed
CN-1633426-A 1, 3-dihydroxybenzene derivatives and coloring agents containing the same WELLA AG (US) 2005-06-29 CN disclosed
EP-1392673-B1 1,3-DIHYDROXYBENZENE DERIVATIVES AND COLORANTS CONTAINING SAID COMPOUNDS WELLA AG (DE) 2005-06-08 EP disclosed
US-20040016063-A1 1,3-Dihydroxybenzene derivatives and colorants containing said compounds HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) 2004-01-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040016063-A1 1,3-Dihydroxybenzene derivatives and colorants containing said compounds KRT18, DSP, COL1A1 RPS6KB2 2994/4885QPCT 3956/4885ERN1 3125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.